迈得医疗：董事长提议以2000万元-4000万元回购股份

Core Viewpoint - The company proposes to repurchase a portion of its shares using funds from its initial public offering or its own funds to reduce registered capital [1] Group 1 - The chairman and actual controller of the company, Lin Junhua, has suggested the share repurchase plan [1] - The total amount for the share repurchase will not be less than RMB 20 million and not exceed RMB 40 million [1] - The repurchase period is set to be within 12 months from the date of approval by the company's shareholders' meeting [1]